- Home
- Equipment
- usa minnesota
- drug therapy
Show results for
Refine by
Drug Therapy Equipment Supplied In Usa Minnesota
5 equipment items found
Manufactured by:Ellex Inc. based inMinneapolis, MINNESOTA (USA)
The Ellex Solo™ is an advanced SLT (selective laser trabeculoplasty) laser which allows you to perform quick and highly accurate glaucoma laser treatment customized to each individual patient’s response. SLT is gentle and non-invasive, which means you can stimulate healthy trabecular meshwork cell regeneration and manage IOP without producing burn scar tissue. ...
Manufactured by:Rebiotix Inc., a Ferring Company based inRoseville, MINNESOTA (USA)
The human microbiome is defined as the microbial community (bacteria, fungi, viruses and protozoa) present in the human body. The human microbiome aids in the maintenance and development of the immune system and metabolism among other body functions. The densest and most diverse microbial community has been found in the human gastrointestinal tract. There is also increasing evidence that the gut ...
Manufactured by:Minnetronix Medical based inSt. Paul, MINNESOTA (USA)
Delivering custom RF technologies, quickly and reliably. Our RF-specific processes incorporate time-tested learnings and best practices to solve the toughest problems from design through manufacturing, without compromising customization or performance. ...
Manufactured by:Minnetronix Medical based inSt. Paul, MINNESOTA (USA)
Skilled in the precise control of fluid and gases. Our deep experience in designing for and managing fluid dynamics and motor control results in devices that perform reliably and consistently. ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%). The effects diminish ...